GAO Issues Report: Treatment With Injectable, Implantable Buprenorphine
CR - GAO Reports
Copyright © Targeted News Service, 2020
Copyright © Targeted News Service, 2020
2020-08-05
Targeted News Service
WASHINGTON, Aug. 5 -- The Government Accountability Office has issued a report (GAO-20-617) entitled "Opioid Use Disorder: Treatment with Injectable and Implantable Buprenorphine".
The report was sent to Sen. Lamar Alexander, R-Tennessee, chairman, Sen. Patty Murray, D-Washington, ranking member of the Senate Health, Education, Labor and Pensions Committee, Rep. Frank Pallone Jr., D-New Jersey, chairman, and Rep. Greg Walden, R-Oregon, ranking member of the House Energy and Commerce . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Aug. 5 -- The Government Accountability Office has issued a report (GAO-20-617) entitled "Opioid Use Disorder: Treatment with Injectable and Implantable Buprenorphine".
The report was sent to Sen. Lamar Alexander, R-Tennessee, chairman, Sen. Patty Murray, D-Washington, ranking member of the Senate Health, Education, Labor and Pensions Committee, Rep. Frank Pallone Jr., D-New Jersey, chairman, and Rep. Greg Walden, R-Oregon, ranking member of the House Energy and Commerce . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com